Age-related hearing loss linked to protein deficiency, study finds
Scientists have discovered a key mechanism behind age-related
hearing loss , and they say a common oral medication could delay its progression.
In a study of crab-eating macaques, the team from China and the United States found that a gradual deficiency in a protein vital to receptor cells in
the ear was a characteristic of cochlear ageing in primates.
The researchers also found that it was possible to slow down age-related hearing loss in the monkeys by using a common diabetes medication called metformin, which they said had potential as a clinical treatment for the condition.
'Our study provides an in-depth characterisation of cellular and molecular ageing patterns in primate cochleae at an unprecedented single-cell resolution,' the team said in a paper published in the peer-reviewed journal Nature Aging on June 20.
'These findings lay the foundation for the development of new treatments for presbycusis and provide the possibility of personalised medicine,' said study author Wang Si, a professor at the Capital Medical University-affiliated Xuanwu Hospital in Beijing.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
South China Morning Post
3 hours ago
- South China Morning Post
New drug approval system takes Hong Kong closer to biomedical hub goal
Hong Kong has good reason to aspire to its own internationally recognised regime for approving pharmaceutical drugs . Intense global demand for Covid-19 vaccines remains fresh in the memory. The city also happens to rank No 2, behind only New York, as a market for biomedical and pharmaceutical companies to raise capital. To realise this goal, developing independent clinical trial capacity and a regulatory framework comparable with the US Food and Drug Administration would go a long way. It would also raise Hong Kong's standing as a medical innovation hub. Advertisement It is therefore good to hear from health authorities that the city will begin reviewing and approving drugs independently in phases from 2026. A new regulatory system is set to begin operating by the end of next year, with more new medications expected to hit the local market before long. To clear the way, the Department of Health has unveiled a plan to set up a centre for the regulation of medical products, with the aim of becoming a recognised international drug regulation authority. This is the final link in a road map for the development of primary drug evaluation, an approach foreshadowed in Chief Executive John Lee Ka-chiu's 2023 policy address. This will speed up product reviews. Primary evaluation means approving drugs based on their clinical trial data, without relying on registration approval from other regulatory authorities. A preparatory office for the centre was set up in June last year to study and plan for a drug regulatory regime. The department said primary evaluation was expected to be implemented gradually over five years. To that end, Hong Kong recently opened its first clinical trial institute , located in a cross-border tech zone. The development of Hong Kong as a biomedical hub not only means business opportunities for the city, but resonates with vast market potential on the mainland, where people cannot always afford new drugs approved in the US. As a rapidly ageing society, Hong Kong has a multipronged interest in recognition as an Asian pharmaceutical and biomedical hub with big potential for healthcare shaped by biotech and bioscience. Advertisement
South China Morning Post
12 hours ago
- South China Morning Post
China-Ghana row over gold, how to claim tax refunds as a tourist: SCMP daily highlights
Catch up on some of SCMP's biggest China stories of the day. If you would like to see more of our reporting, please consider subscribing The leading academic finds grounds for 'moderate optimism' after leading a group of American students on a 10-day tour of China. Factory activity in China edged upwards in June but stayed in contractionary territory for a third straight month, as the country battles soft demand and the effects of a trade war with the United States. People walk past Tesla electric vehicles at the carmaker's delivery centre in Beijing in January. Unique EV features like regenerative braking systems can induce motion sickness, according to researchers. Photo: Reuters After Chinese scientists pinpoint causes of EV motion sickness, Japanese researchers say a simple sound therapy may be the answer.
South China Morning Post
15 hours ago
- South China Morning Post
Age-related hearing loss linked to protein deficiency, study finds
Scientists have discovered a key mechanism behind age-related hearing loss , and they say a common oral medication could delay its progression. In a study of crab-eating macaques, the team from China and the United States found that a gradual deficiency in a protein vital to receptor cells in the ear was a characteristic of cochlear ageing in primates. The researchers also found that it was possible to slow down age-related hearing loss in the monkeys by using a common diabetes medication called metformin, which they said had potential as a clinical treatment for the condition. 'Our study provides an in-depth characterisation of cellular and molecular ageing patterns in primate cochleae at an unprecedented single-cell resolution,' the team said in a paper published in the peer-reviewed journal Nature Aging on June 20. 'These findings lay the foundation for the development of new treatments for presbycusis and provide the possibility of personalised medicine,' said study author Wang Si, a professor at the Capital Medical University-affiliated Xuanwu Hospital in Beijing.
